XETRA - Delayed Quote EUR

Apontis Pharma AG (APPH.DE)

Compare
10.20
+0.10
+(0.99%)
At close: January 10 at 5:36:16 PM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue 12.7M
Earnings --
Q3'21
Q1'24
Q2'24
0
5M
10M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

10.00
13.25 Average
10.20 Current
17.00 High

Earnings Estimate

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----44
Avg. Estimate 000.120.41
Low Estimate 000.090.26
High Estimate 000.130.55
Year Ago EPS -----1.330.12

Revenue Estimate

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----24
Avg. Estimate ----48.75M57.39M
Low Estimate ----48.7M54.9M
High Estimate ----48.8M60.46M
Year Ago Sales ----36.96M48.75M
Sales Growth (year/est) ----31.89%17.73%

EPS Trend

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 000.120.41
7 Days Ago 000.130.46
30 Days Ago 000.130.46
60 Days Ago 000.130.46
90 Days Ago 000.150.47

EPS Revisions

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days ----22
Down Last 30 Days ----22

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
APPH.DE ----108.65%256.52%
S&P 500 8.59%11.42%13.98%13.43%

Related Tickers